Aussie Court Rules For Sirtex In Five-Year Dispute With Cancer Drug Doc
This article was originally published in PharmAsia News
Executive Summary
An Australian court ruled Sirtex Medical may recover from its former director the cost of five years of litigation with the University of Western Australia over invention ownership of a cancer drug